The growth of Viagra and its influence on the drug landscape presents a intricate question for shareholders. While the initial sales data were impressive, the exclusivity has ended, leading to a flood of generic alternatives that are reducing profit. Furthermore, the industry is facing challenges related to population trends and shifting healthc… Read More